VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1631517
Sex: F
Age: 63
State:

Vax Date: 07/10/2021
Onset Date: 07/12/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: confirmed

Allergies: None

Symptom List: Dysphagia, Epiglottitis

Symptoms: Patient developed shingles 2 days after vaccination

Other Meds: Atorvastatin, calcitriol, dabigatran, lenalidomide, loratadine

Current Illness: Multiple myeloma in remission

ID: 1631518
Sex: F
Age: 59
State: CA

Vax Date: 02/23/2021
Onset Date: 03/13/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Mentioned issue to doctor during a visit for a routine physical. Due to ongoing symptoms, I?m considering requesting a referral to an audiologist, however, research shows that no treatment is available.

Allergies: None

Symptom List: Anxiety, Dyspnoea

Symptoms: Tinnitus - mild in left ear only - ongoing for 6+ months .

Other Meds: None

Current Illness: None

ID: 1631520
Sex: M
Age: 70
State: IL

Vax Date: 02/19/2021
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided. Patient received first dose on 19Feb2021 in left non-dominant arm. Patient experienced a sore arm. Patient is scheduled for a colonoscopy. Wants to know if this will affect the second dose vaccine

Other Meds:

Current Illness:

ID: 1631521
Sex: M
Age: 45
State: VA

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: N/A

Allergies: N/A

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: I am a pharmacist and give shots regularly. The nurse gave the shot way too high on the posterior side of the shoulder. It has been 6 months and I am still experiencing intense shoulder pain. Other joints/tendons have also inflamed without any other apparent reason.

Other Meds: Olmesartan/hctz

Current Illness: N/A

ID: 1631522
Sex: F
Age: 82
State: OH

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Sores inside my mouth; Slight Headache; fever; upset Stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset Stomach), ORAL PAIN (Sores inside my mouth), HEADACHE (Slight Headache) and PYREXIA (fever) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 25-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (upset Stomach), HEADACHE (Slight Headache) and PYREXIA (fever). On 28-Feb-2021, the patient experienced ORAL PAIN (Sores inside my mouth). At the time of the report, ABDOMINAL DISCOMFORT (upset Stomach), ORAL PAIN (Sores inside my mouth), HEADACHE (Slight Headache) and PYREXIA (fever) outcome was unknown. No treatment and concomitant medications were not provided. Patient had second Moderna Covid-19 vaccine on Thursday 25FEB2021. On 25FEB2021 and experienced a slight headache, upset stomach, weak, fever. On Sunday 28FEB2021 patient noticed sores inside mouth.

Other Meds:

Current Illness:

ID: 1631523
Sex: F
Age:
State: CA

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PYREXIA (fever) and CHILLS (Chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient stated that she received her 1st dose of the Moderna COVID 19 vaccine on 4FEB2021. Later in the day, she started having side effects. These side effects include fever (97- 102) and terrible chills. The fever lasted for about four days. Tylenol helped a little . She is symptoms free now.

Other Meds:

Current Illness:

ID: 1631524
Sex: M
Age:
State: OR

Vax Date:
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Dry cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Dry cough). At the time of the report, COUGH (Dry cough) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Reporter called reporting that patient who received his 1st dose of the Moderna COVID19 vaccine 2 weeks ago had a dry cough during the whole time of the call

Other Meds:

Current Illness:

ID: 1631525
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Fever; Injection site was red/purple; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Injection site was red/purple) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Injection site was red/purple). At the time of the report, PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Injection site was red/purple) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant medications were not provided by the reporter Treatment information was not provided This case was linked to MOD-2021-031890, MOD-2021-032177 (Patient Link).

Other Meds:

Current Illness:

ID: 1631526
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: shingles; This spontaneous case was reported by a nurse and describes the occurrence of HERPES ZOSTER ( shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER ( shingles). At the time of the report, HERPES ZOSTER ( shingles) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medication were provided. No concomitant medication were provided.

Other Meds:

Current Illness:

ID: 1631527
Sex: F
Age: 73
State: MA

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: she had a catch in her throat which she assumes to be because of nervousness.; bulging of lips; redness of tongue; A spontaneous report was received from a consumer concerning a 73-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events bulging of lips, redness of tongue. The patient's medical history was not provided. No relevant concomitant medications were reported. On 27 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 024M20A) intramuscularly for prophylaxis of COVID-19 infection. On 27 Feb 2021, the patient experienced the events,bulging of lips, redness of tongue,she had a catch in her throat which she assumes to be because of nervousness. No Treatment details included . Action taken with mRNA-1273 in response to the events was unknown. The outcome of events, bulging of lips, redness of tongue , she had catch in her throat which she assumes to be because of nervousness.was unknown.

Other Meds:

Current Illness:

ID: 1631528
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Sore arm; Tiredness for 2 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tiredness for 2 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. Concomitant products included PALBOCICLIB (IBRANCE) for an unknown indication. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tiredness for 2 hours). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tiredness for 2 hours) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Patient reported she took her first shot of Moderna vaccine in her off week of Ibrance. No treatments were provided. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: consumer denied reporting adverse events. No further follow-ups can be done.

Other Meds: IBRANCE

Current Illness:

ID: 1631529
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: got COVID-19 after her first shot; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got COVID-19 after her first shot) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got COVID-19 after her first shot). At the time of the report, COVID-19 (got COVID-19 after her first shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1631530
Sex: F
Age: 66
State: VA

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: she had her lower lip puffy; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (she had her lower lip puffy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 immunisation. Concurrent medical conditions included Hypertension. Concomitant products included ALENDRONATE SODIUM (FOSAMAX) for an unknown indication. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced LIP SWELLING (she had her lower lip puffy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of couple of times. On 10-Feb-2021, LIP SWELLING (she had her lower lip puffy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications also included High blood pressure medications.

Other Meds: FOSAMAX

Current Illness: Hypertension

ID: 1631531
Sex: F
Age: 76
State: PA

Vax Date: 01/30/2021
Onset Date: 02/08/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210208; Test Name: SARS-CoV-2 test positive; Test Result: Positive

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00068720) for COVID-19 vaccination. No Medical History was provided by the reporter. Concurrent medical conditions included Drug allergy. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced COVID-19 (tested positive for Covid). At the time of the report, COVID-19 (tested positive for Covid) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, SARS-CoV-2 test positive: positive Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness: Drug allergy

ID: 1631532
Sex: M
Age: 72
State: CA

Vax Date: 01/23/2021
Onset Date: 02/09/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210209; Test Name: COVID-19 positive; Test Result: Positive ; Result Unstructured Data: positive

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Vomiting; Fatigue; Tested COVID19 positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested COVID19 positive), VOMITING (Vomiting) and FATIGUE (Fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested COVID19 positive). On an unknown date, the patient experienced VOMITING (Vomiting) and FATIGUE (Fatigue). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested COVID19 positive), VOMITING (Vomiting) and FATIGUE (Fatigue) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, SARS-CoV-2 test positive: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: This is a case of a 72-year-old who tested positive for SARS-CoV2 after receiving 1st dose of vaccine. The event is considered unlikely related to the vaccine. Additionally, based on the current available information and temporal association between the use of the product and the start date of the events of vomiting and fatigue, a causal relationship cannot be excluded. Further information has been requested.

Other Meds:

Current Illness:

ID: 1631533
Sex: M
Age:
State:

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Chills; Sweats; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and HYPERHIDROSIS (Sweats) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced CHILLS (Chills) and HYPERHIDROSIS (Sweats). At the time of the report, PYREXIA (Fever), CHILLS (Chills) and HYPERHIDROSIS (Sweats) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1631534
Sex: F
Age: 72
State: MI

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Arm hurts; Head feels like it is about to explode; Chills; Nausea; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts), HEAD DISCOMFORT (Head feels like it is about to explode), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Low grade fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurts), HEAD DISCOMFORT (Head feels like it is about to explode), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Low grade fever). At the time of the report, PAIN IN EXTREMITY (Arm hurts), HEAD DISCOMFORT (Head feels like it is about to explode), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Low grade fever) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Treatment medications were not mentioned by reporter. Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up not required : As reporter declined for further follow-up

Other Meds:

Current Illness:

ID: 1631535
Sex: F
Age: 53
State: MD

Vax Date: 01/29/2021
Onset Date: 02/07/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Red patch; red circle appeared around the injection site; It is itchy; barely hurts.; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of INJECTION SITE ERYTHEMA (Red patch), INJECTION SITE ERYTHEMA (red circle appeared around the injection site), VACCINATION SITE PRURITUS (It is itchy) and VACCINATION SITE PAIN (barely hurts.) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. Concurrent medical conditions included Cholesterol on 07-Feb-2021 and Asthma on 07-Feb-2021. Concomitant products included SALBUTAMOL SULFATE (INHALERIN) for Asthma, PHYTOSTEROLS NOS (CHOLESTROL MANAGER) for Cholesterol. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Red patch), INJECTION SITE ERYTHEMA (red circle appeared around the injection site), VACCINATION SITE PRURITUS (It is itchy) and VACCINATION SITE PAIN (barely hurts.). At the time of the report, INJECTION SITE ERYTHEMA (Red patch), INJECTION SITE ERYTHEMA (red circle appeared around the injection site), VACCINATION SITE PRURITUS (It is itchy) and VACCINATION SITE PAIN (barely hurts.) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment medications were not provided by reporter.

Other Meds: CHOLESTROL MANAGER; INHALERIN

Current Illness:

ID: 1631536
Sex: F
Age: 26
State: MN

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Sore; Tired; Patch of redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sore), FATIGUE (Tired) and VACCINATION SITE ERYTHEMA (Patch of redness) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN (Sore), FATIGUE (Tired) and VACCINATION SITE ERYTHEMA (Patch of redness). On 12-Feb-2021, PAIN (Sore) and FATIGUE (Tired) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Patch of redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment and concomitant medications were not provided by reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1631537
Sex: F
Age: 81
State: FL

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: feeling very sick; FEVERISH; HEADACHE; BODY ACHE; JOINT PAIN; NAUSEOUS; feeling blue and black; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feeling very sick), PYREXIA (FEVERISH), HEADACHE (HEADACHE), MYALGIA (BODY ACHE) and ARTHRALGIA (JOINT PAIN) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Pacemaker insertion (cardiac). Concurrent medical conditions included Hypertension, Diabetes mellitus and Cholesterol. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ILLNESS (feeling very sick), PYREXIA (FEVERISH), HEADACHE (HEADACHE), MYALGIA (BODY ACHE), ARTHRALGIA (JOINT PAIN), NAUSEA (NAUSEOUS) and FEELING ABNORMAL (feeling blue and black). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, ILLNESS (feeling very sick), PYREXIA (FEVERISH), HEADACHE (HEADACHE), MYALGIA (BODY ACHE), ARTHRALGIA (JOINT PAIN), NAUSEA (NAUSEOUS) and FEELING ABNORMAL (feeling blue and black) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were taking medications for HTN, Diabetes, Cholesterol .

Other Meds:

Current Illness: Cholesterol; Diabetes mellitus; Hypertension

ID: 1631538
Sex: M
Age: 84
State:

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body tmperature; Test Result: Inconclusive ; Result Unstructured Data: 99.5

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Nose blistered; Watering of eyes; Loss of appetite; Bleeding of left nose; Weak; Chills; Temperature 99.5; Pressure in chest; Pain in the left shoulder; Pain in left leg; Nose on the left side swell up to the size of golf ball; Stomach discomfort; Severe extreme painful headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Pressure in chest), EPISTAXIS (Bleeding of left nose), NASAL OEDEMA (Nose on the left side swell up to the size of golf ball), BLISTER (Nose blistered) and LACRIMATION INCREASED (Watering of eyes) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (Severe extreme painful headache). On 01-Feb-2021, the patient experienced CHEST DISCOMFORT (Pressure in chest), PAIN IN EXTREMITY (Pain in left leg) and ARTHRALGIA (Pain in the left shoulder). 01-Feb-2021, the patient experienced NASAL OEDEMA (Nose on the left side swell up to the size of golf ball) and ABDOMINAL DISCOMFORT (Stomach discomfort). On an unknown date, the patient experienced EPISTAXIS (Bleeding of left nose), BLISTER (Nose blistered), LACRIMATION INCREASED (Watering of eyes), DECREASED APPETITE (Loss of appetite), ASTHENIA (Weak), CHILLS (Chills) and PYREXIA (Temperature 99.5). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Pressure in chest), NASAL OEDEMA (Nose on the left side swell up to the size of golf ball), BLISTER (Nose blistered), LACRIMATION INCREASED (Watering of eyes), ABDOMINAL DISCOMFORT (Stomach discomfort), ASTHENIA (Weak), PAIN IN EXTREMITY (Pain in left leg), ARTHRALGIA (Pain in the left shoulder), CHILLS (Chills) and PYREXIA (Temperature 99.5) outcome was unknown and EPISTAXIS (Bleeding of left nose), DECREASED APPETITE (Loss of appetite) and HEADACHE (Severe extreme painful headache) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.5 (Inconclusive) 99.5. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were provided.

Other Meds:

Current Illness:

ID: 1631539
Sex: F
Age: 77
State: NY

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Fatigue; Diarrhea; Feeling Unwell; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), DIARRHOEA (Diarrhea) and MALAISE (Feeling Unwell) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included Blood Pressure Medication, PROPRANOLOL and Diuretic Pills for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced FATIGUE (Fatigue), DIARRHOEA (Diarrhea) and MALAISE (Feeling Unwell). At the time of the report, FATIGUE (Fatigue), DIARRHOEA (Diarrhea) and MALAISE (Feeling Unwell) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: Blood Pressure Medication; PROPRANOLOL; Diuretic Pills

Current Illness:

ID: 1631540
Sex: F
Age: 62
State: TX

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: rash on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 immunisation. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1631541
Sex: F
Age:
State: GU

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Body aches; difficulty breathing; Chest pressure; Chills; This spontaneous case was reported by a consumer and describes the occurrence of in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1631542
Sex: M
Age: 59
State: OH

Vax Date: 02/07/2021
Onset Date: 02/07/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Injection site discomfort; Sore shoulder; Wheezing; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (Wheezing), RHINORRHOEA (Runny nose), INJECTION SITE DISCOMFORT (Injection site discomfort) and MYALGIA (Sore shoulder) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. Previously administered products included for an unreported indication: Robaxin. Past adverse reactions to the above products included Hives with Robaxin. Concurrent medical conditions included Parkinson's disease, Obesity and High cholesterol. On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced WHEEZING (Wheezing), RHINORRHOEA (Runny nose) and MYALGIA (Sore shoulder). On an unknown date, the patient experienced INJECTION SITE DISCOMFORT (Injection site discomfort). On 09-Feb-2021, WHEEZING (Wheezing), RHINORRHOEA (Runny nose) and MYALGIA (Sore shoulder) had resolved. At the time of the report, INJECTION SITE DISCOMFORT (Injection site discomfort) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. Patient took prednisone week before a time of vaccination which was not ongoing. Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: NNI Source doc On 09-Jul-2021: Follow up received on 09-Jul-2021, Patient details (height), concomitant medications, concurrent conditions were updated. New event was added.

Other Meds:

Current Illness: High cholesterol; Obesity; Parkinson's disease

ID: 1631543
Sex: M
Age: 82
State: OR

Vax Date: 02/23/2021
Onset Date: 03/02/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Blood vessels shrunk-cant see them as much; hand are ice cold; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 03-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of VASOCONSTRICTION (Blood vessels shrunk-cant see them as much) and PERIPHERAL COLDNESS (hand are ice cold) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VASOCONSTRICTION (Blood vessels shrunk-cant see them as much) and PERIPHERAL COLDNESS (hand are ice cold). At the time of the report, VASOCONSTRICTION (Blood vessels shrunk-cant see them as much) and PERIPHERAL COLDNESS (hand are ice cold) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported. No treatment medication details was reported.

Other Meds:

Current Illness:

ID: 1631544
Sex: F
Age: 91
State: AZ

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Bump/lump; Itchy; Swollen; Little burning; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little burning), VACCINATION SITE MASS (Bump/lump), PRURITUS (Itchy) and VACCINATION SITE SWELLING (Swollen) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (Little burning). On 11-Feb-2021, the patient experienced VACCINATION SITE MASS (Bump/lump), PRURITUS (Itchy) and VACCINATION SITE SWELLING (Swollen). On 05-Feb-2021, VACCINATION SITE PAIN (Little burning) had resolved. At the time of the report, VACCINATION SITE MASS (Bump/lump), PRURITUS (Itchy) and VACCINATION SITE SWELLING (Swollen) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment details included Unknown.

Other Meds:

Current Illness:

ID: 1631545
Sex: F
Age: 75
State: GA

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Sore arm; Face was red; Could hardly walk; Fever of 100.4; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Face was red), GAIT DISTURBANCE (Could hardly walk), PYREXIA (Fever of 100.4) and FATIGUE (Fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included PREDNISONE for Polymyalgia rheumatica. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Face was red), GAIT DISTURBANCE (Could hardly walk), PYREXIA (Fever of 100.4) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, Fever, Fatigue and Gait disturbance, at an unspecified dose and frequency. On 28-Feb-2021, PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Face was red), GAIT DISTURBANCE (Could hardly walk), PYREXIA (Fever of 100.4) and FATIGUE (Fatigue) had resolved. Concomitant medication include prednisone. Treatment medication include Tylenol. Action taken with mRNA-1273(Moderna COVID-19Vaccine) (intramuscular) was not applicable.

Other Meds: PREDNISONE

Current Illness:

ID: 1631546
Sex: F
Age:
State:

Vax Date: 02/28/2021
Onset Date: 03/01/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: diarrhea; dizziness; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (dizziness) and FATIGUE (fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (dizziness) and FATIGUE (fatigue). At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (dizziness) and FATIGUE (fatigue) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment Information was not reported. Concomitant product information was not reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1631547
Sex: F
Age: 69
State: TN

Vax Date: 02/26/2021
Onset Date: 03/03/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: dizzines was turbulent; falling on floor, like she was serverly drunk; was very wonky, fogginess; nausea; not being able to get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzines was turbulent), FALL (falling on floor, like she was serverly drunk), FEELING ABNORMAL (was very wonky, fogginess), NAUSEA (nausea) and FATIGUE (not being able to get out of bed) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE BESILATE, TELMISARTAN (MICARDIS AMLO) and VITAMIN D AND ANALOGUES for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIZZINESS (dizzines was turbulent), FALL (falling on floor, like she was serverly drunk), FEELING ABNORMAL (was very wonky, fogginess), NAUSEA (nausea) and FATIGUE (not being able to get out of bed). On 03-Mar-2021, DIZZINESS (dizzines was turbulent), FALL (falling on floor, like she was serverly drunk), FEELING ABNORMAL (was very wonky, fogginess), NAUSEA (nausea) and FATIGUE (not being able to get out of bed) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant products included ALLERGY MEDICATION. No treatment medication details was reported.

Other Meds: MICARDIS AMLO; VITAMIN D AND ANALOGUES

Current Illness:

ID: 1631548
Sex: F
Age: 38
State: TX

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202102; Test Name: Glucose tolerence; Result Unstructured Data: Normal; Test Date: 20200828; Test Name: Pregnancy test; Test Result: Positive ; Result Unstructured Data: Positive

Allergies:

Symptom List: Injection site pain

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 38-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication. On 02-Mar-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 27-Jul-2020 and the estimated date of delivery was 03-May-2021. On 02-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-first week of the pregnancy. On 02-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Aug-2020, Glucose tolerance test:. On 28-Aug-2020, Pregnancy test: positive (Positive) Positive. In February 2021, Glucose tolerance test: normal (normal) Normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication details was reported.

Other Meds: PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS

Current Illness:

ID: 1631549
Sex: F
Age: 60
State: IL

Vax Date: 02/08/2021
Onset Date: 03/01/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: headache; sinus infection; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinus infection), OROPHARYNGEAL PAIN (sore throat) and HEADACHE (headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced SINUSITIS (sinus infection) and OROPHARYNGEAL PAIN (sore throat). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with AMOXICILLIN, CLAVULANIC ACID (AUGMENTIN BAMBINI) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, SINUSITIS (sinus infection), OROPHARYNGEAL PAIN (sore throat) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: VITAMIN D 2000

Current Illness:

ID: 1631550
Sex: F
Age: 57
State: PA

Vax Date: 02/17/2021
Onset Date: 02/28/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: warm to touch; red, hot area, like a rash on my left arm; swollen; red, hot area, like a rash on my left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red, hot area, like a rash on my left arm), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE RASH (red, hot area, like a rash on my left arm) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No reported medical history. Concomitant products included METFORMIN, FENOFIBRATE, SIMVASTATIN, DULAGLUTIDE, CETIRIZINE and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red, hot area, like a rash on my left arm), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE RASH (red, hot area, like a rash on my left arm). At the time of the report, VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red, hot area, like a rash on my left arm), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE RASH (red, hot area, like a rash on my left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: No specific follow-up information recorded.

Other Meds: METFORMIN; FENOFIBRATE; SIMVASTATIN; DULAGLUTIDE; CETIRIZINE; VITAMIN D 2000

Current Illness:

ID: 1631551
Sex: F
Age:
State:

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: achiness; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN (achiness) and HEADACHE (headache). At the time of the report, PAIN (achiness) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1631552
Sex: F
Age: 69
State: IN

Vax Date: 02/23/2021
Onset Date: 02/25/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202011; Test Name: COVID-19

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Fatigue; Sore arm; Body ache; Chills; Fever; No taste; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body ache), CHILLS (Chills), PYREXIA (Fever) and AGEUSIA (No taste) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. Concomitant products included METOPROLOL, ROSUVASTATIN CALCIUM (CRESTOR), SPIRONOLACTONE and GABAPENTIN for an unknown indication. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PAIN (Body ache), CHILLS (Chills), PYREXIA (Fever) and AGEUSIA (No taste). On an unknown date, the patient experienced FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), PAIN (Body ache), CHILLS (Chills), PYREXIA (Fever), AGEUSIA (No taste) and FATIGUE (Fatigue) outcome was unknown. Possible DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test positive: other. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. concomitant medication include some non prescribed pain killers.

Other Meds: METOPROLOL; CRESTOR; SPIRONOLACTONE; GABAPENTIN

Current Illness:

ID: 1631553
Sex: M
Age: 44
State: DC

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Blood pressure went up; Heart rate went up; He felt warm sensation when vaccine was going in the body; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Blood pressure went up), HEART RATE INCREASED (Heart rate went up) and FEELING HOT (He felt warm sensation when vaccine was going in the body) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure went up), HEART RATE INCREASED (Heart rate went up) and FEELING HOT (He felt warm sensation when vaccine was going in the body). At the time of the report, BLOOD PRESSURE INCREASED (Blood pressure went up), HEART RATE INCREASED (Heart rate went up) and FEELING HOT (He felt warm sensation when vaccine was going in the body) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment and concomitant medications were not provided by reporter.

Other Meds:

Current Illness:

ID: 1631554
Sex: F
Age: 58
State: MS

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210302; Test Name: Body temperature; Result Unstructured Data: 100.3

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Arm ache; Body ache; Temperature of 100.3; lips blistered; little shortness of breath; stuffy nose; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm ache), MYALGIA (Body ache), PYREXIA (Temperature of 100.3), LIP BLISTER (lips blistered) and DYSPNOEA (little shortness of breath) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (Arm ache), MYALGIA (Body ache), PYREXIA (Temperature of 100.3), LIP BLISTER (lips blistered), DYSPNOEA (little shortness of breath), NASAL CONGESTION (stuffy nose) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Arm ache), MYALGIA (Body ache), PYREXIA (Temperature of 100.3), LIP BLISTER (lips blistered), DYSPNOEA (little shortness of breath), NASAL CONGESTION (stuffy nose) and CHILLS (chills) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 100.3 (High) 100.3. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications are provided.

Other Meds:

Current Illness:

ID: 1631555
Sex: M
Age:
State: CA

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: slightly ill; achy; chills; A SPONTANEOUS report was received concerning a male patient who received Moderna's COVID-19 vaccine SHOT-2 on 23-feb-2021(mRNA-1273) and experienced slightly illness, achy and chills, The patient's medical history was unknown / not provided Event or Problem is unknown After the second shot, Ihe became slightly ill, achy, chills (went away after a day). Treatment information was unknown. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the events were Recovered.

Other Meds:

Current Illness:

ID: 1631556
Sex: F
Age: 27
State: CA

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20201014; Test Name: Pregnancy test; Test Result: Positive ; Result Unstructured Data: Positive

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 27-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in September 2020 and the estimated date of delivery was 11-Jun-2021. On 04-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. On 04-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Oct-2020, Pregnancy test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. On an unknown date, an ultrasound and genetic testing were performed and resulted in normal findings.

Other Meds:

Current Illness:

ID: 1631557
Sex: U
Age:
State:

Vax Date: 03/03/2021
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: soreness in arm; swollen lymph node in neck; discomfort in neck; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness in arm), LYMPHADENOPATHY (swollen lymph node in neck) and NECK PAIN (discomfort in neck) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (soreness in arm), LYMPHADENOPATHY (swollen lymph node in neck) and NECK PAIN (discomfort in neck). At the time of the report, MYALGIA (soreness in arm) and NECK PAIN (discomfort in neck) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. Treatment medications was not provided.

Other Meds:

Current Illness:

ID: 1631558
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Pregnant; fever; chills; Body aches; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of PREGNANCY (Pregnant), PYREXIA (fever), CHILLS (chills) and MYALGIA (Body aches) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The patient's last menstrual period was on 09-Jul-2020 and the estimated date of delivery was 11-Apr-2021. On an unknown date, the patient experienced PREGNANCY (Pregnant), PYREXIA (fever), CHILLS (chills) and MYALGIA (Body aches). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. The delivery occurred. At the time of the report, PREGNANCY (Pregnant), PYREXIA (fever), CHILLS (chills) and MYALGIA (Body aches) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was withdrawn on an unknown date. For mRNA-1273 (Moderna COVID-19 Vaccine), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1631559
Sex: F
Age: 73
State: WI

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: after few hours, I started feeling dizzy; shaking; started having diarrhea; lost control of my body; wet my pants; I couldn't control my bladder; felt like this all day Friday; chills; threw up; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (after few hours, I started feeling dizzy), TREMOR (shaking), DIARRHOEA (started having diarrhea), URINARY INCONTINENCE (lost control of my body) and URINARY INCONTINENCE (wet my pants) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included AMLODIPINE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DIZZINESS (after few hours, I started feeling dizzy), TREMOR (shaking), DIARRHOEA (started having diarrhea), URINARY INCONTINENCE (lost control of my body), URINARY INCONTINENCE (wet my pants), BLADDER DISCOMFORT (I couldn't control my bladder), DISCOMFORT (felt like this all day Friday), CHILLS (chills) and VOMITING (threw up). At the time of the report, DIZZINESS (after few hours, I started feeling dizzy), TREMOR (shaking), DIARRHOEA (started having diarrhea), URINARY INCONTINENCE (lost control of my body), URINARY INCONTINENCE (wet my pants), BLADDER DISCOMFORT (I couldn't control my bladder), DISCOMFORT (felt like this all day Friday), CHILLS (chills) and VOMITING (threw up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment for the event included drank plenty of water

Other Meds: AMLODIPINE; VITAMIN D 2000; ASPIRIN (E.C.)

Current Illness:

ID: 1631560
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: had a reaction to the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (had a reaction to the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced ADVERSE REACTION (had a reaction to the second dose). At the time of the report, ADVERSE REACTION (had a reaction to the second dose) outcome was unknown. Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced ADVERSE REACTION (reaction). This case was linked to MOD-2021-034310, MOD-2021-034310 (Patient Link). Reporter did not allow further contact This case was linked to MOD-2021-034310, MOD-2021-034310 (Patient Link). Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1631561
Sex: F
Age: 71
State: WA

Vax Date: 01/22/2021
Onset Date: 02/19/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: sore arm; Headache; Body aches; A spontaneous report was received from a consumer, concerning a 71 years adult female patient, who received Moderna COVID-19 Vaccine and experienced 2 doses. The patient's medical history was not provided. The concomitant products was not provided. On 22-Jan-2021,prior to the onset of events,the patient received the first dose of mRNA-1273(lot number: Unknown) and she had taken the second dose on 19-Feb-2021 route of administration is intramuscular route for COVID-19 infection prophylaxis. On 30JAN2021 she had a 3 inch square below her injection site which was really red, swollen and tender to touch which gradually spread to her elbow and shoulder. It did not hurt to use her arm. This lasted about a week after which she was fine. Her second dose was administered on Feb 19th. She experienced headache, body aches, no fever. Treatment includes Benadryl and Tylenol per doctor recommendation. Action taken with mRNA-1273 in response to the events were not reported. The Outcome of the event (Headache,Myalgia,Sorearm) was considered to be not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1631562
Sex: M
Age: 85
State: TX

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: had temp. 98.9 F; arm soreness,feeling lil pain in his arm; redness which is now 3-4 in long at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness which is now 3-4 in long at the site of injection), PYREXIA (had temp. 98.9 F) and MYALGIA (arm soreness,feeling lil pain in his arm) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (redness which is now 3-4 in long at the site of injection) and MYALGIA (arm soreness,feeling lil pain in his arm). On an unknown date, the patient experienced PYREXIA (had temp. 98.9 F). At the time of the report, INJECTION SITE ERYTHEMA (redness which is now 3-4 in long at the site of injection), PYREXIA (had temp. 98.9 F) and MYALGIA (arm soreness,feeling lil pain in his arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. no concomitant medication provided

Other Meds:

Current Illness:

ID: 1631563
Sex: F
Age: 68
State: VA

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: like a cord from the swollen lymph node extending to the side of her breast; big lump on her left armpit/swollen lymph node; felt very tired; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (felt very tired), LYMPHADENOPATHY (big lump on her left armpit/swollen lymph node) and LYMPHADENOPATHY (like a cord from the swollen lymph node extending to the side of her breast) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced FATIGUE (felt very tired). On 26-Jan-2021, the patient experienced LYMPHADENOPATHY (big lump on her left armpit/swollen lymph node). On 02-Feb-2021, the patient experienced LYMPHADENOPATHY (like a cord from the swollen lymph node extending to the side of her breast). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Tiredness, at an unspecified dose and frequency. On 23-Jan-2021, FATIGUE (felt very tired) had resolved. At the time of the report, LYMPHADENOPATHY (big lump on her left armpit/swollen lymph node) was resolving and LYMPHADENOPATHY (like a cord from the swollen lymph node extending to the side of her breast) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. no concomitation medication provided

Other Meds:

Current Illness:

ID: 1631564
Sex: M
Age:
State: CO

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: dizziness; weakness; constipation; A spontaneous report was received from a healthcare professional concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events dizziness, weakness, constipation. The patient's medical history was not provided. No relevant concomitant medications were reported. On 9 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 010M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 9 Feb 2021, the patient experienced the event(s) dizziness. weakness, constipation. Treatment details included laxative. Action taken with mRNA-1273 in response to the events were not applicable. The outcome of event(s) dizziness was considered resolved on 10 Feb 2021.The outcome of event(s) weakness was considered resolved on 10 Feb 2021. The outcome of event(s), constipation, was unknown.

Other Meds:

Current Illness: Dialysis (Dialysis taking in non-dominant arm)

ID: 1631565
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Long bruise-like and 2 inches wide; A spontaneous report was received from a consumer concerning a female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced 5-inch long bruise-like and 2 inches wide. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the event the patient received their dose of mRNA-1273 (Batch Number: Unknown) for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced big-like bruise on her 8 days after having the Moderna shot. On 21 Jan 2021, in evening patient experienced 5-inch long bruise-like and 2 inches wide. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event, 5-inch long bruise-like and 2 inches wide was not reported.; Reporter's Comments: Based on the current available information which includes a temporal association between the use of the product and the start date of the reported event, and excluding any other etiology, a causal relationship with the event cannot be excluded.

Other Meds:

Current Illness:

ID: 1631566
Sex: M
Age: 78
State: FL

Vax Date: 01/27/2021
Onset Date:
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Mild Cough that is worsening; dizziness; lightheadedness; loose stools; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Mild Cough that is worsening), DIZZINESS (dizziness), DIZZINESS (lightheadedness) and DIARRHOEA (loose stools) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (Mild Cough that is worsening), DIZZINESS (dizziness), DIZZINESS (lightheadedness) and DIARRHOEA (loose stools). At the time of the report, COUGH (Mild Cough that is worsening), DIZZINESS (dizziness), DIZZINESS (lightheadedness) and DIARRHOEA (loose stools) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1631567
Sex: F
Age: 75
State: IL

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/25/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Dizziness; Tightening around the circumfrence of my face; Tinnitus got worse; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), MUSCLE TIGHTNESS (Tightening around the circumfrence of my face), TINNITUS (Tinnitus got worse), FATIGUE (Fatigue) and HEADACHE (Headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031620A) for COVID-19 vaccination. Concurrent medical conditions included Tinnitus. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced DIZZINESS (Dizziness), MUSCLE TIGHTNESS (Tightening around the circumfrence of my face), TINNITUS (Tinnitus got worse), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness), MUSCLE TIGHTNESS (Tightening around the circumfrence of my face), TINNITUS (Tinnitus got worse), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: TYLENOL

Current Illness: Tinnitus

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am